{"id":"https://openalex.org/W2173663152","doi":"https://doi.org/10.1089/15209150260007390","title":"Unresolved Challenges with Insulin Therapy in Type 1 and Type 2 Diabetes: Potential Benefit of Replacing Amylin, a Second \u03b2 -Cell Hormone","display_name":"Unresolved Challenges with Insulin Therapy in Type 1 and Type 2 Diabetes: Potential Benefit of Replacing Amylin, a Second \u03b2 -Cell Hormone","alternate_titles":[],"publication_year":2002,"publication_date":"2002-04-01","ids":{"openalex":"https://openalex.org/W2173663152","doi":"https://doi.org/10.1089/15209150260007390","mag":"2173663152","pmid":"https://pubmed.ncbi.nlm.nih.gov/12079621"},"language":"en","primary_location":{"id":"doi:10.1089/15209150260007390","doi":"https://doi.org/10.1089/15209150260007390","is_oa":false,"landing_page_url":"https://doi.org/10.1089/15209150260007390","pdf_url":null,"source":{"id":"https://openalex.org/S67495602","display_name":"Diabetes Technology & Therapeutics","issn_l":"1520-9156","issn":["1520-9156","1557-8593"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Technology &amp; Therapeutics","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2173663152"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5036743289","display_name":"Steven V. Edelman","orcid":"https://orcid.org/0000-0002-0760-9332","observed_orcids":["https://orcid.org/0000-0002-0760-9332"]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"S. V. Edelman","raw_affiliation_strings":["Veteran's Affairs Health Care Systems, University of California, San Diego, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Veteran's Affairs Health Care Systems, University of California, San Diego, California","institution_ids":["https://openalex.org/I36258959"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109551809","display_name":"C. Weyer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"C. Weyer","raw_affiliation_strings":["Amylin Pharmaceuticals Inc., San Diego, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amylin Pharmaceuticals Inc., San Diego, California","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.1093,"has_fulltext":false,"cited_by_count":78,"citation_normalized_percentile":{"value":0.7421981,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":96},"biblio":{"volume":"4","issue":"2","first_page":"175","last_page":"189"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.7577999830245972,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.7577999830245972,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.23469999432563782,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10839","display_name":"Pancreatic function and diabetes","score":0.003000000026077032,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/amylin","display_name":"amylin","score":0.7480000257492065},{"id":"https://openalex.org/keywords/pramlintide","display_name":"pramlintide","score":0.9929999709129333},{"id":"https://openalex.org/keywords/insulin-therapy","display_name":"insulin therapy","score":0.8140000104904175},{"id":"https://openalex.org/keywords/type-1-diabetes","display_name":"type 1 diabetes","score":0.9909999966621399},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9990000128746033},{"id":"https://openalex.org/keywords/postprandial-blood-glucose","display_name":"postprandial blood glucose","score":0.6349999904632568},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.8009999990463257},{"id":"https://openalex.org/keywords/hypoglycemia","display_name":"hypoglycemia","score":0.9520000219345093},{"id":"https://openalex.org/keywords/body-weight","display_name":"body weight","score":0.5740000009536743},{"id":"https://openalex.org/keywords/glucagon-suppression","display_name":"glucagon suppression","score":0.8270000219345093},{"id":"https://openalex.org/keywords/amylin-aggregation","display_name":"amylin aggregation","score":0.5630000233650208},{"id":"https://openalex.org/keywords/adjunctive-therapy","display_name":"adjunctive therapy","score":0.7450000047683716}],"concepts":[{"id":"https://openalex.org/C2780705028","wikidata":"https://www.wikidata.org/wiki/Q424643","display_name":"Amylin","level":4,"score":0.9693118333816528},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8638340830802917},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7678379416465759},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.7435729503631592},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.7350800037384033},{"id":"https://openalex.org/C2780473172","wikidata":"https://www.wikidata.org/wiki/Q5572518","display_name":"Glycemic","level":3,"score":0.7046781778335571},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.6902487874031067},{"id":"https://openalex.org/C2778199505","wikidata":"https://www.wikidata.org/wiki/Q2992990","display_name":"Postprandial","level":3,"score":0.6888450384140015},{"id":"https://openalex.org/C2780668416","wikidata":"https://www.wikidata.org/wiki/Q202758","display_name":"Hypoglycemia","level":3,"score":0.6827749609947205},{"id":"https://openalex.org/C2780533449","wikidata":"https://www.wikidata.org/wiki/Q417762","display_name":"Exenatide","level":4,"score":0.523969829082489},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.4848876893520355},{"id":"https://openalex.org/C2781232474","wikidata":"https://www.wikidata.org/wiki/Q124407","display_name":"Type 1 diabetes","level":3,"score":0.47586601972579956},{"id":"https://openalex.org/C165220095","wikidata":"https://www.wikidata.org/wiki/Q207524","display_name":"Islet","level":3,"score":0.07221618294715881}],"mesh":[{"descriptor_ui":"D000595","descriptor_name":"Amino Acid Sequence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000682","descriptor_name":"Amyloid","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D000682","descriptor_name":"Amyloid","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000682","descriptor_name":"Amyloid","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D003922","descriptor_name":"Diabetes Mellitus, Type 1","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003922","descriptor_name":"Diabetes Mellitus, Type 1","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D006706","descriptor_name":"Homeostasis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D007328","descriptor_name":"Insulin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008969","descriptor_name":"Molecular Sequence Data","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011487","descriptor_name":"Protein Conformation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058228","descriptor_name":"Islet Amyloid Polypeptide","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1089/15209150260007390","doi":"https://doi.org/10.1089/15209150260007390","is_oa":false,"landing_page_url":"https://doi.org/10.1089/15209150260007390","pdf_url":null,"source":{"id":"https://openalex.org/S67495602","display_name":"Diabetes Technology & Therapeutics","issn_l":"1520-9156","issn":["1520-9156","1557-8593"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Technology &amp; Therapeutics","raw_type":"journal-article"},{"id":"pmid:12079621","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12079621","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes technology & therapeutics","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":76,"referenced_works":["https://openalex.org/W130211283","https://openalex.org/W322447970","https://openalex.org/W1535088540","https://openalex.org/W1975452506","https://openalex.org/W1975642953","https://openalex.org/W1978259628","https://openalex.org/W1979515954","https://openalex.org/W1982298257","https://openalex.org/W1982994822","https://openalex.org/W1986955391","https://openalex.org/W1990490378","https://openalex.org/W1990806804","https://openalex.org/W1994056464","https://openalex.org/W1997676993","https://openalex.org/W1999241788","https://openalex.org/W2001910224","https://openalex.org/W2002169861","https://openalex.org/W2007144010","https://openalex.org/W2007442347","https://openalex.org/W2007493089","https://openalex.org/W2007561446","https://openalex.org/W2020358579","https://openalex.org/W2024286178","https://openalex.org/W2026701440","https://openalex.org/W2027629911","https://openalex.org/W2027785653","https://openalex.org/W2028495157","https://openalex.org/W2036939737","https://openalex.org/W2038951352","https://openalex.org/W2041827953","https://openalex.org/W2049275999","https://openalex.org/W2053670472","https://openalex.org/W2060265905","https://openalex.org/W2067820229","https://openalex.org/W2069950551","https://openalex.org/W2074366941","https://openalex.org/W2076531509","https://openalex.org/W2076930788","https://openalex.org/W2085211148","https://openalex.org/W2085369605","https://openalex.org/W2109582726","https://openalex.org/W2110544725","https://openalex.org/W2111112233","https://openalex.org/W2112025233","https://openalex.org/W2115540838","https://openalex.org/W2120624712","https://openalex.org/W2134775254","https://openalex.org/W2138168864","https://openalex.org/W2139075957","https://openalex.org/W2140678948","https://openalex.org/W2141384541","https://openalex.org/W2142380333","https://openalex.org/W2143025008","https://openalex.org/W2149998150","https://openalex.org/W2151702699","https://openalex.org/W2153427324","https://openalex.org/W2157467255","https://openalex.org/W2159836940","https://openalex.org/W2168465164","https://openalex.org/W2188846692","https://openalex.org/W2278474092","https://openalex.org/W2285110265","https://openalex.org/W2317720845","https://openalex.org/W2326971529","https://openalex.org/W2337454357","https://openalex.org/W2512485408","https://openalex.org/W2752336761","https://openalex.org/W2760585829","https://openalex.org/W2769264260","https://openalex.org/W4213149640","https://openalex.org/W4230533844","https://openalex.org/W4230823162","https://openalex.org/W4234329496","https://openalex.org/W4252541576","https://openalex.org/W4252759459","https://openalex.org/W4300780703"],"related_works":["https://openalex.org/W2134775254","https://openalex.org/W2074118400","https://openalex.org/W2065786925","https://openalex.org/W2055928432","https://openalex.org/W3007191000","https://openalex.org/W2141384541","https://openalex.org/W2280211678","https://openalex.org/W2008320711","https://openalex.org/W1982298257","https://openalex.org/W2045124724"],"abstract_inverted_index":{"Current":[0],"insulin":[1,24,65,98,173,215,241],"therapy":[2,129,239],"still":[3],"fails":[4],"to":[5,17,45,68,118,134,155,168,172,240],"safely":[6],"restore":[7],"near-normoglycemia":[8],"in":[9,25,66,73,99,170,184,195,205,212,218],"the":[10,15,95,110,116,119,251],"majority":[11],"of":[12,37,97,112,131,144,157,165,225,229,250,255],"patients.":[13],"Among":[14],"barriers":[16],"achieving":[18],"tight":[19],"long-term":[20,196],"glycemic":[21,197],"control":[22,198],"with":[23,64,75,186,201,234,258],"both":[26],"type":[27,30,76,80,187,190,259,262],"1":[28,77,188,260],"and":[29,42,49,70,78,108,180,189,208,261],"2":[31,81,191,263],"diabetes":[32],"are":[33],"an":[34,237],"increased":[35],"risk":[36],"hypoglycemia,":[38],"undesired":[39],"weight":[40,207],"gain,":[41],"a":[43,57,90,138,202,243],"failure":[44],"normalize":[46],"postprandial":[47,100,105,177],"hyperglycemia":[48],"excessive":[50],"unpredictable":[51],"diurnal":[52],"glucose":[53,101,178],"fluctuations.":[54],"Amylin":[55],"is":[56,62,71,124,242],"second":[58],"beta-cell":[59],"hormone":[60,92],"that":[61,86,93,149,156,246],"cosecreted":[63],"response":[67],"meals,":[69,169],"deficient":[72],"patients":[74,185,257],"insulin-requiring":[79],"diabetes.":[82,192,264],"Preclinical":[83],"studies":[84],"indicate":[85],"amylin":[87,123,232],"acts":[88],"as":[89,236],"neuroendocrine":[91],"complements":[94],"effects":[96],"regulation":[102],"by":[103],"suppressing":[104],"glucagon":[106],"secretion":[107],"slowing":[109],"rate":[111],"nutrient":[113],"delivery":[114],"from":[115],"stomach":[117],"small":[120],"intestine.":[121],"Human":[122],"not":[125],"optimal":[126],"for":[127],"replacement":[128,233],"because":[130],"its":[132],"propensity":[133],"aggregate;":[135],"thus,":[136],"pramlintide,":[137],"soluble,":[139],"nonaggregating":[140],"synthetic":[141],"peptide":[142],"analog":[143],"human":[145,158],"amylin,":[146],"was":[147,199],"developed":[148],"has":[150],"potency":[151],"at":[152],"least":[153],"equal":[154],"amylin.":[159],"In":[160],"clinical":[161,230,253],"studies,":[162],"subcutaneous":[163],"injections":[164],"pramlintide":[166,235],"prior":[167],"addition":[171],"therapy,":[174],"significantly":[175],"reduced":[176],"excursions":[179],"lowered":[181],"HbA(1c)":[182],"levels":[183],"The":[193],"improvement":[194],"associated":[200],"significant":[203],"reduction":[204],"body":[206],"occurred":[209],"without":[210],"increases":[211],"total":[213],"daily":[214],"use":[216],"or":[217],"overall":[219],"severe":[220],"hypoglycemia":[221],"event":[222],"rates.":[223],"Because":[224],"this":[226],"unique":[227],"spectrum":[228],"effects,":[231],"adjunctive":[238],"promising":[244],"approach":[245],"may":[247],"fulfill":[248],"some":[249],"unmet":[252],"needs":[254],"insulin-using":[256]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2173663152","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":3},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
